Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Hepatitis

Free Subscription 20.05.2024 1 Clin Infect Dis 4 Hepatology 6 J Hepatol 3 J Med Virol 3 J Viral Hepat 1 Pediatr Infect Dis J 3 PLoS One 1 Z Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Clin Infect Dis

1. LO RE V 3RD, Price JC, Schmitt S, Terrault N, et al
   The Obstacle is the Way: Finding a Path to Hepatitis C Elimination.
   Clin Infect Dis. 2024 May 16:ciae231. doi: 10.1093.
   PubMed        
   
   

   
   Hepatology

2. LO RE V 3RD, Price JC, Schmitt S, Terrault N, et al
   The obstacle is the way: Finding a path to hepatitis C elimination.
   Hepatology. 2024 May 16. doi: 10.1097/HEP.0000000000000807.
   PubMed        
   
   
3. LUO C
   Letter to the Editor: Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-Positive patients.
   Hepatology. 2024 May 14. doi: 10.1097/HEP.0000000000000928.
   PubMed        
   
   
4. HALL EW, Bradley H, Barker LK, Lewis K, et al
   Estimating hepatitis C prevalence in the United States, 2017-2020.
   Hepatology. 2024 May 13. doi: 10.1097/HEP.0000000000000927.
   PubMed         Abstract available
   
   
5. HOWELL J, Hellard ME
   Reply: Provider preparedness for functional cure of chronic hepatitis B.
   Hepatology. 2024;79:E160.
   PubMed        
   
   

   
   J Hepatol

6. SHIHA G, Mikhail N, Soliman R
   Validation of SMART Model for HCC Risk stratification in genotype -4 HCV Patients following SVR and its comparison with GES score.
   J Hepatol. 2024 May 15:S0168-8278(24)00348-9. doi: 10.1016/j.jhep.2024.
   PubMed        
   
   
7. BABLON P, Goy C, Dang HN, Sotty J, et al
   Hepatitis B Virus spliced 1 RNA, a key factor for viral expression.
   J Hepatol. 2024 May 9:S0168-8278(24)00331-3. doi: 10.1016/j.jhep.2024.
   PubMed        
   
   
8. YANG F, Fan X, Zhou L, Yang L, et al
   Need for risk stratification in treatment of patients with autoimmune hepatitis.
   J Hepatol. 2024 May 9:S0168-8278(24)00338-6. doi: 10.1016/j.jhep.2024.
   PubMed        
   
   
9. ALLWEISS L, Volmari A, Suri V, Wallin JJ, et al
   Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies.
   J Hepatol. 2024 Feb 8:S0168-8278(24)00114-4. doi: 10.1016/j.jhep.2024.
   PubMed         Abstract available
   
   
10. CHUNG CY, Sun CP, Tao MH, Wu HL, et al
    Major HBV splice variant encoding a novel protein important for infection.
    J Hepatol. 2024;80:858-867.
    PubMed         Abstract available
    
    
11. XU M, Warner C, Duan X, Cheng Z, et al
    HIV coinfection exacerbates HBV-induced liver fibrogenesis through a HIF-1alpha- and TGF-beta1-dependent pathway.
    J Hepatol. 2024;80:868-881.
    PubMed         Abstract available
    
    

    
    J Med Virol

12. TAN A, He Y, Zhou Y, Peng X, et al
    A potential antiviral role for CCR5+CD8+ T cells in children with hepatitis B.
    J Med Virol. 2024;96:e29661.
    PubMed         Abstract available
    
    
13. LIU CH, Chang YP, Lee JY, Chen CY, et al
    Four weeks of off-treatment follow-up is sufficient to determine virologic responses at off-treatment week 12 in patients with hepatitis C virus infection receiving fixed-dose pangenotypic direct-acting antivirals.
    J Med Virol. 2024;96:e29675.
    PubMed         Abstract available
    
    
14. LI Q, Wen W, Wang Y, Gong T, et al
    Autophagy-related protein 5 (ATG5) interacts with bone marrow stromal cell antigen 2 (BST2) to stimulate HBV replication through antagonizing the antiviral activity of BST2.
    J Med Virol. 2024;96:e29659.
    PubMed         Abstract available
    
    

    
    J Viral Hepat

15. IRVIN R, Landry G, Jones MR, James A, et al
    High prevalence of hepatitis C virus infection among incarcerated persons: Results from the Louisiana Hepatitis C Elimination Plan's opt-out testing program in prisons.
    J Viral Hepat. 2024 May 17. doi: 10.1111/jvh.13941.
    PubMed         Abstract available
    
    
16. MESZAROS M, Coursier S, Nagot N, Moulis L, et al
    Screening for hepatitis C virus at the time of mammography using rapid diagnostic tests in women aged between 50 and 74 years (Mamm'OC NCT05067374).
    J Viral Hepat. 2024 May 15. doi: 10.1111/jvh.13947.
    PubMed         Abstract available
    
    
17. ROUSSOS S, Bagos C, Angelopoulos T, Chaikalis S, et al
    Incidence of primary hepatitis C infection among people who inject drugs during 2012-2020 in Athens, Greece.
    J Viral Hepat. 2024 May 14. doi: 10.1111/jvh.13951.
    PubMed         Abstract available
    
    

    
    Pediatr Infect Dis J

18. MUSTO F, Stracuzzi M, Crivellaro E, Rubinacci V, et al
    Natural History and Management of Hepatitis C in Children: 25 Years Experience of a Reference Center in Northern Italy.
    Pediatr Infect Dis J. 2024 May 17. doi: 10.1097/INF.0000000000004374.
    PubMed         Abstract available
    
    

    
    PLoS One

19. HAGOS YM, Yalew GT, Meles HN, Tsegay E, et al
    Hepatitis B and C viral coinfection and associated factors among HIV-positive patients attending ART clinics of Afar regional state, northeast Ethiopia.
    PLoS One. 2024;19:e0302453.
    PubMed         Abstract available
    
    
20. GOLAM RM, Khalil MAF, Shaker OG, Ahmed TI, et al
    The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the diagnosis of HCV-related hepatocellular carcinoma.
    PLoS One. 2024;19:e0303314.
    PubMed         Abstract available
    
    
21. PEWKLIANG Y, Thongsri P, Suthivanich P, Thongbaiphet N, et al
    Immortalized hepatocyte-like cells: A competent hepatocyte model for studying clinical HCV isolate infection.
    PLoS One. 2024;19:e0303265.
    PubMed         Abstract available
    
    

    
    Z Gastroenterol

22. PRECHAL D, Arntzen D, Klaas L, Paulmann M, et al
    [DRESS as a rare differential diagnosis in eosinophilia, skin rash and acute hepatitis].
    Z Gastroenterol. 2024 May 15. doi: 10.1055/a-2300-0620.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.